ZA200605589B - 2-micron family plasmid and use thereof - Google Patents

2-micron family plasmid and use thereof

Info

Publication number
ZA200605589B
ZA200605589B ZA200605589A ZA200605589A ZA200605589B ZA 200605589 B ZA200605589 B ZA 200605589B ZA 200605589 A ZA200605589 A ZA 200605589A ZA 200605589 A ZA200605589 A ZA 200605589A ZA 200605589 B ZA200605589 B ZA 200605589B
Authority
ZA
South Africa
Prior art keywords
gene
family plasmid
micron family
last
base
Prior art date
Application number
ZA200605589A
Other languages
English (en)
Inventor
Sleep Darrell
Finnis Christopher John Arthur
Original Assignee
Delta Biotechnology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delta Biotechnology Ltd filed Critical Delta Biotechnology Ltd
Publication of ZA200605589B publication Critical patent/ZA200605589B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
ZA200605589A 2003-12-23 2004-12-23 2-micron family plasmid and use thereof ZA200605589B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0329722.3A GB0329722D0 (en) 2003-12-23 2003-12-23 Modified plasmid and use thereof

Publications (1)

Publication Number Publication Date
ZA200605589B true ZA200605589B (en) 2007-12-27

Family

ID=30776295

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200605589A ZA200605589B (en) 2003-12-23 2004-12-23 2-micron family plasmid and use thereof

Country Status (14)

Country Link
US (1) US8252551B2 (de)
EP (1) EP1711602B1 (de)
JP (1) JP4964596B2 (de)
KR (1) KR101298157B1 (de)
CN (2) CN1922326B (de)
AT (1) ATE483812T1 (de)
AU (1) AU2004303597C1 (de)
CA (1) CA2551496C (de)
DE (1) DE602004029503D1 (de)
DK (1) DK1711602T3 (de)
GB (2) GB0329722D0 (de)
NZ (1) NZ548154A (de)
WO (1) WO2005061719A1 (de)
ZA (1) ZA200605589B (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2475382A1 (en) * 2002-02-07 2003-08-14 Delta Biotechnology Limited Albumin-fused anti-angiogenesis peptides
US9057061B2 (en) 2003-12-23 2015-06-16 Novozymes Biopharma Dk A/S Gene expression technique
WO2006067511A1 (en) 2004-12-23 2006-06-29 Novozymes Delta Limited Gene expression technique
GB0329722D0 (en) 2003-12-23 2004-01-28 Delta Biotechnology Ltd Modified plasmid and use thereof
CN101006174B (zh) * 2004-06-21 2010-05-26 诺维信公司 以相同取向稳定保持的至少两个orf的多拷贝
GB0512707D0 (en) * 2005-06-22 2005-07-27 Delta Biotechnology Ltd Gene expression technique
CA2695830A1 (en) 2007-08-08 2009-02-12 Novozymes Biopharma Dk A/S Transferrin variants and conjugates
WO2010089385A1 (en) 2009-02-06 2010-08-12 Novozymes Biopharma Dk A/S Purification process
WO2010092135A2 (en) 2009-02-11 2010-08-19 Novozymes Biopharma Uk Ltd. Albumin variants and conjugates
CN102741280B (zh) 2009-10-30 2015-12-02 诺维信生物制药丹麦公司 白蛋白变体
CN106977608A (zh) 2010-04-09 2017-07-25 阿尔布麦狄克斯公司 白蛋白衍生物和变体
CN101974547B (zh) * 2010-07-30 2012-06-27 天津大学 含FLP的pBBR1MCS-2重组质粒及运动发酵单胞菌基因组DNA修饰的方法
CA2810244C (en) 2010-09-07 2020-10-06 Butamax(Tm) Advanced Biofuels Llc Integration of a polynucleotide encoding a polypeptide that catalyzes pyruvate to acetolactate conversion
US20120088271A1 (en) * 2010-09-30 2012-04-12 Codexis, Inc. Use of an Endogenous 2-Micron Yeast Plasmid for Gene Over Expression
US9790521B2 (en) 2011-03-24 2017-10-17 Butamax Advanced Biofuels Llc Host cells and methods for production of isobutanol
HK1200842A1 (en) 2011-11-18 2015-08-14 Albumedix Ltd Proteins with improved half-life and other properties
WO2013102147A2 (en) 2011-12-30 2013-07-04 Butamax (Tm) Advanced Biofuels Llc Genetic switches for butanol production
EP2808388B1 (de) 2012-01-23 2019-03-13 AGC Inc. Expressionsvektor und verfahren zur herstellung von protein
MX2014010278A (es) 2012-03-16 2015-03-05 Novozymes Biopharma Dk As Variantes de albumina.
CN104902929A (zh) * 2012-05-21 2015-09-09 沈维强 使用蛋白质前体作为前药的方法
WO2014072481A1 (en) 2012-11-08 2014-05-15 Novozymes Biopharma Dk A/S Albumin variants
CN103898142B (zh) * 2014-03-04 2016-03-02 北京理工大学 一种硫醇过氧化物酶提高毕赤酵母外源蛋白质表达量的方法
CN105087520B (zh) * 2014-05-21 2018-07-20 中国科学院上海生命科学研究院 一种促进重组极端耐热α-淀粉酶可溶性表达的方法
CN104946659A (zh) * 2015-03-27 2015-09-30 杭州北斗生物技术有限公司 重组人生长激素的制备方法及其peg化修饰物的制备方法
WO2017029407A1 (en) 2015-08-20 2017-02-23 Albumedix A/S Albumin variants and conjugates
WO2017112847A1 (en) * 2015-12-22 2017-06-29 Albumedix A/S Improved protein expression strains
CN109153985B (zh) * 2016-01-12 2022-02-22 Ａｇｃ株式会社 转化体、以及转铁蛋白的制造方法
CN107367619A (zh) * 2017-08-30 2017-11-21 福建师范大学 Tcp1蛋白在制备乳腺癌术后预后评估试剂盒中的应用、乳腺癌预后评估试剂盒及方法
DK3775222T5 (da) * 2018-03-26 2024-08-19 Novozymes As Chaperoneproteiner fra svampe
CN110184292B (zh) * 2019-06-17 2023-01-20 湖北大学 一种利用分子伴侣提高酵母细胞表面展示功能性Infliximab Fab片段的方法
CN112680371A (zh) * 2019-10-18 2021-04-20 广东利世康低碳科技有限公司 一种水解餐厨垃圾中蛋白成分的产朊假丝酵母双基因共表达菌株及其构建方法
CN110592090A (zh) * 2019-10-30 2019-12-20 福建师范大学 Ssa4基因启动子及利用该启动子驱动外源基因转录的毕赤酵母表达载体
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
CN112501141A (zh) * 2020-10-22 2021-03-16 重庆中元汇吉生物技术有限公司 一种增加人甲状腺过氧化物酶产量的试剂和表达方法
CN116744984A (zh) 2020-12-28 2023-09-12 达沃有限公司 包含蛋白质和多官能化改性的基于聚乙二醇的交联剂的反应性干粉状止血材料
CN114410496B (zh) * 2022-02-16 2023-10-03 江南大学 一种提高毕赤酵母外源蛋白产量的方法
CN114957488A (zh) * 2022-05-19 2022-08-30 中国科学院生物物理研究所 芳香烃受体蛋白稳定高效表达的方法及其应用
GB202301984D0 (en) 2023-02-13 2023-03-29 Phenotypeca Ltd Engineered eukaryotic cell
GB202301983D0 (en) 2023-02-13 2023-03-29 Phenotypeca Ltd Engineered eukaryotic cell
GB202301988D0 (en) 2023-02-13 2023-03-29 Phenotypeca Ltd Breeding process

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9019919D0 (en) 1990-09-12 1990-10-24 Delta Biotechnology Ltd Purification of proteins
US4302386A (en) * 1978-08-25 1981-11-24 The Ohio State University Antigenic modification of polypeptides
NZ199722A (en) 1981-02-25 1985-12-13 Genentech Inc Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
IL66614A (en) 1981-08-28 1985-09-29 Genentech Inc Method of constructing a dna sequence encoding a polypeptide,microbial production of human serum albumin,and pharmaceutical compositions comprising it
GB8615701D0 (en) * 1986-06-27 1986-08-06 Delta Biotechnology Ltd Stable gene integration vector
GB8620926D0 (en) 1986-08-29 1986-10-08 Delta Biotechnology Ltd Yeast promoter
EP0286424B1 (de) * 1987-04-09 1994-03-16 Delta Biotechnology Limited Hefevektor
IL86455A0 (en) 1987-06-01 1988-11-15 Takeda Chemical Industries Ltd Polypeptide and production thereof
IL88326A (en) 1987-11-18 1993-03-15 Gist Brocades Nv Purification of serum albumin
AU626288B2 (en) 1988-02-05 1992-07-30 Commonwealth Scientific And Industrial Research Organisation Gene expression system (particularly for rotavirus vp7 protein) involving a foreign signal peptide and optionally a transmembrane anchor sequence
AU633020B2 (en) 1988-07-23 1993-01-21 Novozymes Delta Limited New secretory leader sequences
US5759802A (en) 1988-10-26 1998-06-02 Tonen Corporation Production of human serum alubumin A
GB8909916D0 (en) 1989-04-29 1989-06-14 Delta Biotechnology Ltd Polypeptides
US5571691A (en) * 1989-05-05 1996-11-05 Baylor College Of Medicine Production of recombinant lactoferrin and lactoferrin polypeptides using CDNA sequences in various organisms
GB8927480D0 (en) 1989-12-05 1990-02-07 Delta Biotechnology Ltd Mutant fungal strain detection and new promoter
JP3230091B2 (ja) 1990-06-25 2001-11-19 ウェルファイド株式会社 ヒト血清アルブミンの着色抑制方法
AU8299191A (en) * 1990-07-13 1992-02-04 Transkaryotic Therapies, Inc. Library screening method
GB2249096A (en) * 1990-10-11 1992-04-29 Ciba Geigy Saccharomyces cerevisiae strains lacking carboxypeptidase yscY activity for expression of proteins at high yields
CA2103583C (en) * 1991-02-08 2009-10-13 Walter D. Funk Recombinant transferrins, transferrin half-molecules and mutants thereof
SG84484A1 (en) * 1991-02-25 2001-11-20 Ciba Geigy Ag Improved yeast vectors
EP0509841A3 (en) 1991-04-18 1993-08-18 Tonen Corporation Co-expression system of protein disulfide isomerase gene and useful polypeptide gene and process for producing the polypeptide using its system
ZA932568B (en) * 1992-04-24 1993-11-12 Baylor College Midecine A Non Production of recombinant human lactoferrin
US6291205B1 (en) * 1992-06-12 2001-09-18 Merck & Co., Inc. Method of increasing production of disulfide bonded recombinant proteins by saccharomyces cerevisiae
AU4571993A (en) 1992-07-29 1994-03-03 Unilever Plc Process for producing anti-freeze peptides
DE4244915C2 (de) 1992-08-14 1998-12-03 Widmar Prof Dr Tanner DNA-Moleküle codierend Proteine, die an der O-Glykosylierung von Proteinen beteiligt sind
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
EP0663010B1 (de) * 1992-10-02 2000-08-09 Research Corporation Technologies, Inc. Methoden der erhöhung der sekretion von überexpremierten proteinen
GB9404270D0 (en) 1994-03-05 1994-04-20 Delta Biotechnology Ltd Yeast strains and modified albumins
GB9411356D0 (en) 1994-06-07 1994-07-27 Delta Biotechnology Ltd Yeast strains
JP3945866B2 (ja) * 1996-09-04 2007-07-18 サントリー株式会社 メタノール酵母由来のプロテインジスルフィドイソメラーゼ遺伝子
GB9703406D0 (en) * 1997-02-19 1997-04-09 Chiron Spa Expression of heterologous proteins
AU8040798A (en) 1997-06-13 1998-12-30 Stichting Instituut Voor Dierhouderij En Diergezondheid Increased production of proteins by using chaperone-like proteins
GB9713412D0 (en) 1997-06-26 1997-08-27 Delta Biotechnology Ltd Improved protein expression strains
WO1999013093A1 (en) * 1997-09-05 1999-03-18 Pentapharm Ag Expression vector for improved production of polypeptides in yeast
IT1306207B1 (it) 1999-01-15 2001-05-30 Biopolo S C A R L Produzione di proteine eterologhe da zygosaccharomyces bailii.
GB9902000D0 (en) * 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
EP1274720A4 (de) 2000-04-12 2004-08-18 Human Genome Sciences Inc Albumin enthaltende fusionsproteine
US7176278B2 (en) * 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins
US20030226155A1 (en) * 2001-08-30 2003-12-04 Biorexis Pharmaceutical Corporation Modified transferrin-antibody fusion proteins
CA2475382A1 (en) 2002-02-07 2003-08-14 Delta Biotechnology Limited Albumin-fused anti-angiogenesis peptides
WO2004015113A2 (en) 2002-08-07 2004-02-19 Delta Biotechnology Ltd. Albumin-fused ciliary neurotrophic factor
DE10252245A1 (de) 2002-11-07 2004-05-27 Prof. Dr. Danilo Porro Università degli Studi di Milano-Bicocca Dipartimento die Biotechnologie e Bioscienze Verfahren zur Expression und Sekretion von Proteinen mittels der nicht-konventionellen Hefe Zygosaccharomyces bailii
US6939676B2 (en) * 2002-12-30 2005-09-06 The United States Of America As Represented By The Secretary Of Argriculture Selection procedure for identifying transgenic cells, embryos, and plants without the use of antibiotics
GB0305989D0 (en) 2003-03-15 2003-04-23 Delta Biotechnology Ltd Agent
WO2006067511A1 (en) 2004-12-23 2006-06-29 Novozymes Delta Limited Gene expression technique
GB0329681D0 (en) * 2003-12-23 2004-01-28 Delta Biotechnology Ltd Gene expression technique
GB0329722D0 (en) 2003-12-23 2004-01-28 Delta Biotechnology Ltd Modified plasmid and use thereof
GB0402660D0 (en) 2004-02-06 2004-03-10 Medical Res Council Heterologous protein expression
WO2005113768A1 (ja) * 2004-05-21 2005-12-01 Takara Bio Inc. ポリペプチドの製造方法

Also Published As

Publication number Publication date
WO2005061719A1 (en) 2005-07-07
DE602004029503D1 (de) 2010-11-18
CN101128587B (zh) 2014-02-12
GB2424888B (en) 2008-03-26
EP1711602B1 (de) 2010-10-06
DK1711602T3 (da) 2011-01-31
CA2551496C (en) 2014-12-09
US20080261861A1 (en) 2008-10-23
GB0614610D0 (en) 2006-08-30
GB2424888A (en) 2006-10-11
AU2004303597C1 (en) 2009-05-14
NZ548154A (en) 2009-05-31
US8252551B2 (en) 2012-08-28
ATE483812T1 (de) 2010-10-15
JP2007515961A (ja) 2007-06-21
AU2004303597A1 (en) 2005-07-07
CN101128587A (zh) 2008-02-20
CA2551496A1 (en) 2005-07-07
AU2004303597B2 (en) 2008-09-25
GB0329722D0 (en) 2004-01-28
JP4964596B2 (ja) 2012-07-04
CN1922326B (zh) 2011-02-09
EP1711602A1 (de) 2006-10-18
KR20070004585A (ko) 2007-01-09
CN1922326A (zh) 2007-02-28
KR101298157B1 (ko) 2013-08-21

Similar Documents

Publication Publication Date Title
GB2424888B (en) 2-Micron family plasmid and use thereof
EP1590471A4 (de) Zusammensetzungen, verfahren und systeme zur bestimmung von rindermerkmalen
IL139080A0 (en) Btx inhibitors and methods for their indentification and use
AP2421A (en) Quinoline derivatives and their use as mycobacterial inhibitors.
WO2001051083A3 (en) Innate immunity-stimulating compositions of cpg and saponin and methods thereof
CY1108547T1 (el) Αναλογα σωματοστατινης
AU2003220205A8 (en) Ethanol-diesel fuel composition and methods thereof
TW200611910A (en) Interferon-alpha polypeptides and conjugates
MXPA02000973A (es) Benzofurilpiperazinas y benzofurilhomopiperazinas: agonistas de serotonina.
NO20016003L (no) Miljömessig akseptable brönnsementfluidtapskontrolladditiver, sammensetninger og fremgangsmåter
ZA200303794B (en) Heterocyclylalkyl piperidine derivatives, their preparation and compositions containing same.
AU8738401A (en) Novel kallikrein gene
HUP0300909A3 (en) 2-guanidino-4-arylchinazolines as nhe-3 inhibitors, pharmaceutical compositions containing them and their use
IL171990A0 (en) Novel 8-aza-bicyclo[3,2,1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
AU2003285906A8 (en) Amylases, nucleic acids encoding them and methods for making and using them
PL358287A1 (en) Tampering tip
EP1592443A4 (de) Verbesserte anthraximpfstoffe und abgabeverfahren
AP2006003530A0 (en) Immunogenic HIV compositions and related methods.
MXPA03000512A (es) Oxiguanidina-pirazinonas ciclicas como inhibidores de proteasas.
IL173166A0 (en) Flame retardants with high halogen content and low viscosity
MY145375A (en) Pharmaceutical composition
MXPA05009428A (es) Composiciones y metodos para prevenir y tratar enfermedades relacionadas con endotoxinas.
NO20052478D0 (no) Vitamin D-analoger, sammensetninger omfattende analogene og deres anvendelse.
HUP0301384A3 (en) Urotensin-ii agonists and antagonists
PL1664179T3 (pl) Opóźniacze palenia o wysokiej zawartości halogenów i niskiej lepkości